7:47 PM ET
Form 4
Insider Buying
Iambic Therapeutics Director Evan Lockwood Rachlin Buys $11.5M of Stock
Evan Lockwood Rachlin, Director, bought 718,750 shares of Iambic Therapeutics, Inc. at $16.00 a share, worth $11.5M in total on Oct 16, 2026. Shares held after the trade: 2,588,248 (+38.4%).
- Value
- $11.5M
- Shares
- 718,750
- Price
- $16.00
- Role
- Director
- Holding change
- +38.4%
- Trade date
- Oct 16, 2026